Ann: ATL1102 for MS and DMD Update, page-18

Mr LEARNER.
If ANP was an empty vessel I would be concerned.
However ANP have 3 Antisense drugs with each having many indications..
ANP have to give at least 21 days notice for an AGM.
ANP is in the process of rewriting the trial for RRMS.SPMS.DMD.and also rewriting the MS,NDF,applications for $funds.The staff at ANP are very busy,so all this nonsense about "second strike"is just simply NOISE!
AEI has not left the building because they now know for a fact that ATL1102 has been approved for RRMS and SPMS...starting at a lower dose moving to a higher dose.AEI will take 20% of ANP...which I WELCOME.
The DMD study is going to be the Prime mover for AMP's Share price.
Sarepta only addresses 13% of DMD sufferers,and has a MC of over $2 billion.
George Soros has increased his funds stake in IONIS...... Ionis is almost at its highs...Ionis has no safety issues in P3 and FDA approved drugs(thrombus problems have been addressed...so Atl 1102 will use that data and methods to rewrite )..ANTISENSE will be a WORLDWIDE NAME.
WE WAIT !!!!